title: Response to "Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury".
authors.forename: Emily C
authors.initials: EC
authors.lastname: Somers
authors.forename: Gregory M
authors.initials: GM
authors.lastname: Christman
authors.forename: Senait
authors.initials: S
authors.lastname: Fisseha
authors.forename: Wendy
authors.initials: W
authors.lastname: Marder
authors.forename: W Joseph
authors.initials: WJ
authors.lastname: McCune
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists / Q000627:therapeutic use*; D006801:Humans; D010053:Ovary / Q000187:drug effects*; D016649:Primary Ovarian Insufficiency / Q000139:chemically induced* / Q000517:prevention & control; D020011:Protective Agents / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D020011:Protective Agents; D007987:Gonadotropin-Releasing Hormone